← 產業報告目錄

Clinical Trial Equipment & Ancillary Solutions Market Size, Share & Trends Analysis Report By Product (Sourcing (Procurement, Rental), Supply/Logistics, Service, Others), By Phase (Phase I, II, III, IV), Region And Segment Forecasts, 2024-2031

出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-18頁數 180報告編號 INSIGHTACE-7ac43fb02d

授權報價

Single User PDF$4,500 USD
Global Site License PDF$9,500 USD
洽詢購買 申請 Sample

報告摘要

With a 2023 valuation of USD 2.71 billion, the global Clinical Trial Equipment & Ancillary Solutions Market is anticipated to increase to USD 5.16 billion by 2031, demonstrating a CAGR of 8.61% during the 2024–2031 forecast window. Clinical Trial Equipment & Ancillary Solutions covers The increased investment in research and development projects fosters innovation and creates new equipment and solutions. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space. Several factors contribute to this trajectory, including heightened call for next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives. The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion. From a regional perspective, mature markets in North America and Europe continue to hold substantial shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and growing investment in the sector. Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players. This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Clinical Trial Equipment & Ancillary Solutions Market Snapshot Chapter 4. Global Clinical Trial Equipment & Ancillary Solutions Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis – Porter's Five Forces Analysis 4.7. Competitive Landscape & Market Share Analysis 4.8. Impact of Covid-19 Analysis Chapter 5. Market Segmentation 1: by Product Estimates & Trend Analysis 5.1. by Product & Market Share, 2019 & 2031 5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Product: 5.2.1. Sourcing 5.2.1.1. Procurement 5.2.1.1.1. Equipment 5.2.1.1.2. Ancillaries 5.2.1.2. Rental 5.2.1.2.1. Equipment 5.2.1.2.2. Ancillaries 5.2.2. Supply/Logistics 5.2.2.1. Transportation 5.2.2.2. Packaging 5.2.2.3. Others 5.2.3. Service 5.2.3.1. Calibrations 5.2.3.2. Equipment servicing 5.2.3.3. Others 5.2.4. Others Chapter 6. Market Segmentation 2: by Phase Estimates & Trend Analysis 6.1. by Phase & Market Share, 2019 & 2031 6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Phase: 6.2.1. Phase I 6.2.2. Phase II 6.2.3. Phase III 6.2.4. Phase IV Chapter 7. Clinical Trial Equipment & Ancillary Solutions Market Segmentation 3: Regional Estimates & Trend Analysis 7.1. North America 7.1.1. North America Clinical Trial Equipment & Ancillary Solutions Market Revenue (US$ Million) Estimates and Forecasts by Product, 2019-2031 7.1.2. North America Clinical Trial Equipment & Ancillary Solutions Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2019-2031 7.1.3. North America Clinical Trial Equipment & Ancillary Solutions Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031 7.2. Europe 7.2.1. Europe Clinical Trial Equipment & Ancillary Solutions Market Revenue (US$ Million) Estimates and Forecasts by Product, 2019-2031 7.2.2. Europe Clinical Trial Equipment & Ancillary Solutions Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2019-2031 7.2.3. Europe Clinical Trial Equipment & Ancillary Solutions Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031 7.3. Asia Pacific 7.3.1. Asia Pacific Clinical Trial Equipment & Ancillary Solutions Market Revenue (US$ Million) Estimates and Forecasts by Product, 2019-2031 7.3.2. Asia Pacific Clinical Trial Equipment & Ancillary Solutions Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2019-2031 7.3.3. Asia Pacific Clinical Trial Equipment & Ancillary Solutions Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031 7.4. Latin America 7.4.1. Latin America Clinical Trial Equipment & Ancillary Solutions Market Revenue (US$ Million) Estimates and Forecasts by Product, 2019-2031 7.4.2. Latin America Clinical Trial Equipment & Ancillary Solutions Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2019-2031 7.4.3. Latin America Clinical Trial Equipment & Ancillary Solutions Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031 7.5. Middle East & Africa 7.5.1. Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market Revenue (US$ Million) Estimates and Forecasts by Product, 2019-2031 7.5.2. Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2019-2031 7.5.3. Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031 Chapter 8. Competitive Landscape 8.1. Major Mergers and Acquisitions/Strategic Alliances 8.2. Company Profiles 8.2.1. Ancillare, LP 8.2.2. Imperial Clinical Research Services 8.2.3. Woodley Equipment Company Ltd. 8.2.4. Thermo Fisher Scientific, Inc. 8.2.5. PPD, Inc. 8.2.6. PAREXEL International Corp. 8.2.7. MediCapital Rent 8.2.8. Quipment SAS 8.2.9. IRM 8.2.10. Marken 8.2.11. Myonex 8.2.12. Yourway 8.2.13. Other Prominent Players

量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們